These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass. Radovits T, Korkmaz S, Miesel-Gröschel C, Seidel B, Stasch JP, Merkely B, Karck M, Szabó G. Eur J Cardiothorac Surg; 2011 Feb 01; 39(2):248-55. PubMed ID: 20591683 [Abstract] [Full Text] [Related]
14. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction. Fraccarollo D, Widder JD, Galuppo P, Thum T, Tsikas D, Hoffmann M, Ruetten H, Ertl G, Bauersachs J. Circulation; 2008 Aug 19; 118(8):818-27. PubMed ID: 18678774 [Abstract] [Full Text] [Related]
15. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction. Poulsen SH. Dan Med Bull; 2001 Nov 19; 48(4):199-210. PubMed ID: 11767125 [Abstract] [Full Text] [Related]
17. The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies. Sharina IG, Sobolevsky M, Papakyriakou A, Rukoyatkina N, Spyroulias GA, Gambaryan S, Martin E. Br J Pharmacol; 2015 May 19; 172(9):2316-29. PubMed ID: 25536881 [Abstract] [Full Text] [Related]
18. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction. Kompa AR, See F, Lewis DA, Adrahtas A, Cantwell DM, Wang BH, Krum H. J Pharmacol Exp Ther; 2008 Jun 19; 325(3):741-50. PubMed ID: 18334667 [Abstract] [Full Text] [Related]